170 related articles for article (PubMed ID: 32449779)
1. Mogamulizumab-induced Mucocutaneous Lichenoid Reaction: A Case Report and Short Review.
Trager MH; de Clippelé D; Ram-Wolff C; de Masson A; Vignon-Pennamen MD; Battistella M; Michel L; Bagot M; Dobos G
Acta Derm Venereol; 2020 May; 100(10):adv00158. PubMed ID: 32449779
[TBL] [Abstract][Full Text] [Related]
2. Mogamulizumab-induced photosensitivity in patients with mycosis fungoides and other T-cell neoplasms.
Masuda Y; Tatsuno K; Kitano S; Miyazawa H; Ishibe J; Aoshima M; Shimauchi T; Fujiyama T; Ito T; Tokura Y
J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1456-1460. PubMed ID: 29341283
[TBL] [Abstract][Full Text] [Related]
3. Bilateral Lower Extremity Skin Eruptions in an HIV-Positive Man Receiving Pembrolizumab Monotherapy for Non-Small Cell Lung Cancer.
Boozalis E; Kwatra SG; Marrone KA
JAMA Oncol; 2019 Feb; 5(2):261-262. PubMed ID: 30286225
[No Abstract] [Full Text] [Related]
4. Lichenoid eruption associated with antituberculous drug; an unusual oral and follicular involvement.
Byun JW; Bang CY; Choi GS; Shin J
Am J Dermatopathol; 2014 Aug; 36(8):684-5. PubMed ID: 23823026
[No Abstract] [Full Text] [Related]
5. Hypertrophic lichenoid eruption due to furosemide.
Arias-Santiago S; Aneiros-Fernandez J; Aceituno-Madera P; Burkhardt-Perez P; Naranjo Sintes R
Acta Derm Venereol; 2010; 90(1):78-9. PubMed ID: 20107731
[No Abstract] [Full Text] [Related]
6. Oral lichenoid lesions after hepatitis B vaccination.
Pemberton MN; Sloan P; Thakker NS
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Jun; 89(6):717-9. PubMed ID: 10846126
[TBL] [Abstract][Full Text] [Related]
7. Resolution of pembrolizumab-associated lichenoid dermatitis with a single dose of methotrexate.
Varma A; Friedlander P; De Moll EH; Desman G; Levitt J
Dermatol Online J; 2020 May; 26(5):. PubMed ID: 32621697
[TBL] [Abstract][Full Text] [Related]
8. Digital ulcerative lichenoid dermatitis in a patient receiving anti-PD-1 therapy.
Martínez-Doménech Á; García-Legaz Martínez M; Magdaleno-Tapial J; Valenzuela-Oñate C; Pérez-Pastor G; Pérez-Ferriols A
Dermatol Online J; 2019 Sep; 25(9):. PubMed ID: 31738845
[TBL] [Abstract][Full Text] [Related]
9. Real-world experience with mechlorethamine gel in patients with mycosis fungoides-cutaneous lymphoma: Preliminary findings from a prospective observational study.
Kim EJ; Geskin L; Guitart J; Querfeld C; Girardi M; Musiek A; Mink DR; Williams MJ; Angello JT; Bailey WL
J Am Acad Dermatol; 2020 Sep; 83(3):928-930. PubMed ID: 32089294
[No Abstract] [Full Text] [Related]
10. Mogamulizumab in the treatment of advanced mycosis fungoides and Sézary syndrome: safety and efficacy.
Lewis DJ; Rook AH
Expert Rev Anticancer Ther; 2020 Jun; 20(6):447-452. PubMed ID: 32320304
[TBL] [Abstract][Full Text] [Related]
11. Tocilizumab-induced pustular drug eruption.
Mori T; Yamamoto T
Int J Rheum Dis; 2017 Nov; 20(11):1776-1777. PubMed ID: 26218136
[No Abstract] [Full Text] [Related]
12. Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy.
Siegel J; Totonchy M; Damsky W; Berk-Krauss J; Castiglione F; Sznol M; Petrylak DP; Fischbach N; Goldberg SB; Decker RH; Stamatouli AM; Hafez N; Glusac EJ; Tomayko MM; Leventhal JS
J Am Acad Dermatol; 2018 Dec; 79(6):1081-1088. PubMed ID: 30025829
[TBL] [Abstract][Full Text] [Related]
13. Eruptive keratoacanthomas arising in the setting of lichenoid toxicity after programmed cell death 1 inhibition with nivolumab.
Feldstein SI; Patel F; Larsen L; Kim E; Hwang S; Fung MA
J Eur Acad Dermatol Venereol; 2018 Feb; 32(2):e58-e59. PubMed ID: 28776778
[No Abstract] [Full Text] [Related]
14. Spotlight on Mogamulizumab-Kpkc for Use in Adults with Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome: Efficacy, Safety, and Patient Selection.
Blackmon AL; Pinter-Brown L
Drug Des Devel Ther; 2020; 14():3747-3754. PubMed ID: 32982179
[TBL] [Abstract][Full Text] [Related]
15. Lichenoid drug eruption with palmoplantar hyperkeratosis due to imatinib mesylate: a case report and a review of the literature.
Kuraishi N; Nagai Y; Hasegawa M; Ishikawa O
Acta Derm Venereol; 2010; 90(1):73-6. PubMed ID: 20107730
[TBL] [Abstract][Full Text] [Related]
16. Mogamulizumab-induced toxicoderma-like eruptions and autoimmune hepatitis successfully treated with azathioprine in adult T-cell leukaemia/lymphoma.
Nishizawa A; Ishikawa T; Hirose M; Satoh H; Nishii S; Tomita K; Hokari R; Satoh T
Eur J Dermatol; 2017 Dec; 27(6):651-652. PubMed ID: 28739547
[No Abstract] [Full Text] [Related]
17. Adverse Reactions to Biologics: Melanoma (Ipilimumab, Nivolumab, Pembrolizumab).
Hwang SJE; Fernández-Peñas P
Curr Probl Dermatol; 2018; 53():82-92. PubMed ID: 29131040
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institution retrospective analysis with stratification of reactions by toxicity and implications for management.
Coleman E; Ko C; Dai F; Tomayko MM; Kluger H; Leventhal JS
J Am Acad Dermatol; 2019 Apr; 80(4):990-997. PubMed ID: 30399387
[TBL] [Abstract][Full Text] [Related]
19. Lichenoid drug eruption related to imatinib: report of a new case and review of the literature.
Sendagorta E; Herranz P; Feito M; Ramírez P; Feltes R; Floristán U; Mariño-Enriquez A; Casado M
Clin Exp Dermatol; 2009 Oct; 34(7):e315-6. PubMed ID: 19456782
[No Abstract] [Full Text] [Related]
20. Nivolumab-induced lichenoid penile ulceration and re-emergent mucocutaneous eruption treated with hydroxychloroquine.
Headd VA; Mathien A; Pei S; Kuraitis D
Australas J Dermatol; 2024 Jun; 65(4):e97-e99. PubMed ID: 38337182
[No Abstract] [Full Text] [Related]
[Next] [New Search]
